WeTrials
Recruiting

A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1310 in Subjects With Advanced/Metastatic Solid Tumors

What is this study?

This study is testing a new experimental anti-cancer drug called DB-1310 for people with advanced solid tumors. Researchers want to find the safest and most effective dose to help fight cancer that has spread.

Who can participate?

Adults 18 and older can join if they have advanced cancer that has not responded well to standard treatments or if other options are not available. Participants also need to be well enough to handle daily activities and have a healthy heart.

What will happen?

Participants will receive the study medication and have regular check-ups to monitor their health and tumor size through imaging scans. The team will closely watch for any side effects to ensure your safety throughout the process.

Where and when?

This study is currently recruiting participants at multiple locations, including Sacramento and Santa Monica in California, and Coral Gables in Florida. You can check with your doctor to see if one of these locations works for you.

Key Points
  • 1Testing a new drug called DB-1310 for advanced cancers
  • 2Currently recruiting new participants at specific medical centers
  • 3Regular monitoring and scans will track your safety and progress

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Advanced Solid Tumor

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.